These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11027825)

  • 1. Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses.
    Kunisawa J; Okudaira A; Tsutusmi Y; Takahashi I; Nakanishi T; Kiyono H; Mayumi T
    Vaccine; 2000 Oct; 19(4-5):589-94. PubMed ID: 11027825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
    Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination.
    Nakase H; Okazaki K; Tabata Y; Uchida K; Uose S; Ohana M; Nishi T; Watanabe T; Matsuura M; Hisatsune H; Matsumura K; Itoh T; Kawanami C; Chiba T
    Vaccine; 2001 Nov; 20(3-4):377-84. PubMed ID: 11672900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
    Tabata Y; Inoue Y; Ikada Y
    Vaccine; 1996 Dec; 14(17-18):1677-85. PubMed ID: 9032899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity.
    Kuo-Haller P; Cu Y; Blum J; Appleton JA; Saltzman WM
    Mol Pharm; 2010 Oct; 7(5):1585-95. PubMed ID: 20698574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
    Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
    Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery.
    Bae HD; Lee J; Jin XH; Lee K
    Mol Pharm; 2016 Sep; 13(9):3196-205. PubMed ID: 27454469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Systemic and Mucosal Immune Responses Induced by a Nasal Powder Delivery System in Conjunction with an OVA Antigen in Cynomolgus Monkeys.
    Torikai Y; Sasaki Y; Sasaki K; Kyuno A; Haruta S; Tanimoto A
    J Pharm Sci; 2021 May; 110(5):2038-2046. PubMed ID: 33278410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization.
    Matsunaga Y; Wakatsuki Y; Tabata Y; Kawasaki H; Usui T; Yoshida M; Itoh T; Habu S; Kita T
    Vaccine; 2000 Oct; 19(4-5):579-88. PubMed ID: 11027824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannan-decorated thiolated Eudragit microspheres for targeting antigen presenting cells via nasal vaccination.
    Li HS; Singh B; Park TE; Hong ZS; Kang SK; Cho CS; Choi YJ
    Eur J Pharm Sci; 2015 Dec; 80():16-25. PubMed ID: 26415829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
    Howe SE; Konjufca VH
    PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system.
    Oh YK; Park JS; Yoon H; Kim CK
    Vaccine; 2003 May; 21(17-18):1980-8. PubMed ID: 12706687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size effect on the antibody production induced by biodegradable microspheres containing antigen.
    Nakaoka R; Inoue Y; Tabata Y; Ikada Y
    Vaccine; 1996 Sep; 14(13):1251-6. PubMed ID: 8961514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.